News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AlphaMed Pharmaceuticals Awarded $750,000 Grant for Its Targeted Melanoma Therapy



5/7/2008 9:18:34 AM

ACTON, Mass.--(BUSINESS WIRE)--AlphaMed Inc. has been awarded a $750,000 peer review grant from the National Cancer Institute to continue development of its targeted melanoma therapy.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES